Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 27, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 29, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-323842
Filed / recorded
Jul 29, 2026, 8:30 PM UTC
Added to OQRO
Oct 6, 2026, 4:40 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
ASHLAND INC.
Issuer CIK
1674862
Ticker
ASH
Reporting person
Alessandra Faccin Assis
Relationship
Officer
Officer title
SVP and GM, Life Sciences
Security
Restricted Stock Unit
Table
Derivative (Table II)
Transaction date
Jul 27, 2026
Transaction code
M
Shares / units
3,215
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
9,646
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.
On July 25, 2024, the Reporting Person was granted 15,234 restricted stock units, vesting over a three-year period, with 20% vesting on July 25, 2025, 20% vesting on July 25, 2026, and 60% vesting on July 25, 2027, provided that the Reporting Person remains in continuous employment with the Issuer.
Balance includes additional common stock or restricted stock units acquired in lieu of cash dividends.